Blutspendedienst SRK Bern AG Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2012
NCT01519830
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Blutspendedienst SRK Bern AG, 3008 Bern, Switzerland | Blutspendedienst SRK Bern AG, Bern, Switzerland